1. Home
  2. DAO vs PCRX Comparison

DAO vs PCRX Comparison

Compare DAO & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAO
  • PCRX
  • Stock Information
  • Founded
  • DAO 2006
  • PCRX 2006
  • Country
  • DAO China
  • PCRX United States
  • Employees
  • DAO N/A
  • PCRX N/A
  • Industry
  • DAO Other Consumer Services
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAO Real Estate
  • PCRX Health Care
  • Exchange
  • DAO Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • DAO 1.0B
  • PCRX 1.2B
  • IPO Year
  • DAO 2019
  • PCRX 2011
  • Fundamental
  • Price
  • DAO $8.66
  • PCRX $22.55
  • Analyst Decision
  • DAO
  • PCRX Buy
  • Analyst Count
  • DAO 0
  • PCRX 8
  • Target Price
  • DAO N/A
  • PCRX $28.38
  • AVG Volume (30 Days)
  • DAO 46.1K
  • PCRX 565.4K
  • Earning Date
  • DAO 08-21-2025
  • PCRX 08-05-2025
  • Dividend Yield
  • DAO N/A
  • PCRX N/A
  • EPS Growth
  • DAO N/A
  • PCRX N/A
  • EPS
  • DAO 0.17
  • PCRX N/A
  • Revenue
  • DAO $762,395,370.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • DAO $6.70
  • PCRX $7.92
  • Revenue Next Year
  • DAO $13.94
  • PCRX $11.02
  • P/E Ratio
  • DAO $50.82
  • PCRX N/A
  • Revenue Growth
  • DAO N/A
  • PCRX 3.08
  • 52 Week Low
  • DAO $2.86
  • PCRX $11.16
  • 52 Week High
  • DAO $11.82
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • DAO 45.13
  • PCRX 43.85
  • Support Level
  • DAO $8.57
  • PCRX $21.26
  • Resistance Level
  • DAO $8.88
  • PCRX $22.95
  • Average True Range (ATR)
  • DAO 0.14
  • PCRX 0.83
  • MACD
  • DAO -0.01
  • PCRX 0.01
  • Stochastic Oscillator
  • DAO 31.25
  • PCRX 48.68

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: